Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Sherwin-Williams maintains Peerperform rating amid 1Q earnings

EditorNatashya Angelica
Published 24/04/2024, 01:04 am
SHW
-

On Tuesday, Sherwin-Williams (NYSE:SHW) retained its Peerperform rating from Wolfe Research following the release of its first-quarter adjusted earnings per share (EPS) of $2.17. This figure fell short of the Financial Sector (FS) consensus estimate of $2.22 and Wolfe Research's own projection of $2.30.

Despite this, the company's full-year guidance remained unchanged at $10.85 to $11.35, with expectations for the second quarter suggesting consolidated sales ranging from flat to a low single-digit increase, aligning with Wolfe Research's model of a 0.9% rise.

The first-quarter results were characterized as disappointing by the research firm, citing a challenging demand environment for the first half of 2024. This current situation is expected to temporarily overshadow the long-term positive outlook for Sherwin-Williams, which is supported by factors such as the housing market and market share gains.

Sherwin-Williams' financial performance in the first quarter has drawn attention to the broader conditions affecting the industry, particularly as the company navigates a period of subdued demand. The unchanged full-year earnings outlook suggests a steady course for the company, despite the initial shortfall in the first quarter.

The company's anticipation of flat to slightly increased sales in the second quarter indicates a measured approach to growth amid current market challenges. This projection is consistent with Wolfe Research's analysis and expectations for Sherwin-Williams' performance.

In summary, Sherwin-Williams' first-quarter earnings have not prompted Wolfe Research to alter its Peerperform rating for the company's stock. The firm's perspective remains focused on the company's potential over multiple years, despite the near-term headwinds faced in the first half of 2024.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

In light of the recent earnings release by Sherwin-Williams, it’s valuable to consider additional metrics and insights that could further inform investors about the company's financial standing. According to real-time data from InvestingPro, Sherwin-Williams has a market capitalization of $75.42 billion and is trading at a P/E ratio of 33.29, which reflects a premium valuation in the market.

The company's Price/Book ratio stands at 20.55, indicating a relatively high valuation in terms of its net asset value.

From a growth perspective, Sherwin-Williams has reported a revenue growth of 4.08% over the last twelve months as of Q4 2023, showing a consistent upward trajectory in sales. Additionally, the company's EBITDA growth rate during the same period was 18.79%, signaling strong operational efficiency and profitability.

InvestingPro Tips highlight that Sherwin-Williams has been a reliable dividend payer, increasing its dividend for 31 consecutive years and maintaining dividend payments for 46 consecutive years. This track record of dividend growth, coupled with the company's share buyback strategy, underscores its commitment to shareholder returns. Moreover, the company is recognized as a prominent player in the Chemicals industry, which could be a factor in its resilient market performance.

For investors seeking more in-depth analysis, additional InvestingPro Tips, including the latest analyst revisions and stock volatility data, are available at https://www.investing.com/pro/SHW. Furthermore, users can take advantage of an exclusive offer by using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, which includes a wealth of financial insights and investment tips. There are over 15 additional InvestingPro Tips available for Sherwin-Williams that could provide further guidance for investors.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.